CBC (Cannabichromene): Pharmacology and Evidence
CBC (cannabichromene) is a non-intoxicating cannabinoid from CBGA with TRP-channel activity, sparse human data, and limited clinical evidence.
Read articleExpert Knowledge Hub
Cannabinoids
THC, CBD, CBG and all active compounds
CBD as a Drug: Real Doses, Effects and Risks
Explore how CBD acts as a CNS drug: real evidence on high-dose benefits, liver and interaction risks, and why common low-dose wellness claims often exceed data.
Read articleCBD Is Not a CB1 Agonist: How It Really Works
CBD does not activate CB1 like THC. This single fact explains why it feels non‑intoxicating, how it "balances" THC, and why effects vary so widely.
Read articleCBDA (Cannabidiolic Acid): effects, stability, science
CBDA is the main cannabinoid in fresh cannabis. Learn how CBDA is made, how it becomes CBD, its 5-HT1A effects, stability, and legal status.
Read articleCBDV (Cannabidivarin): Chemistry, Trials, and Loss
CBDV differs from CBD by a C3 side chain, a divarinolic-acid pathway, and mixed trial results in autism, Rett syndrome, and epilepsy research.
Read articleCBG (Cannabigerol): biosynthesis, effects, and facts
CBG (cannabigerol) explained: CBGA biosynthesis, why flower tests under 1% CBG, pharmacology, MRSA data, colitis research, and legality.
Read articleCBGA: Precursor Cannabinoid Acid Explained in Cannabis
CBGA is the precursor cannabinoid acid that feeds THCA, CBDA, and CBCA biosynthesis. Learn how CBGA forms, converts, and what research shows.
Read articleCBL Cannabicyclol: CBC Photoproduct After Harvest
CBL Cannabicyclol is a minor cannabinoid formed from CBC by UV light, with sparse pharmacology and clear value as a storage and aging marker.
Read articleCBN (Cannabinol): Chemistry, Sleep, and THC Breakdown
CBN (cannabinol) is a THC oxidation product with weak psychoactivity, limited sleep evidence, and growing relevance in cannabis testing and research.
Read articleDelta-10-THC: Effects, Safety, Chemistry, and Law
Delta-10-THC explained: chemistry, effects, safety, production, and legal status, with a focus on sparse human data and mixed-isomer products.
Read articleDelta-8-THC: pharmacology, risks, and legal status
Delta-8-THC differs from delta-9 in CB1 activity, is usually made from CBD, and raises contamination, poisoning, and legal concerns worldwide.
Read articleHHC Cannabinoid Guide: Effects, Safety and Legal Status
HHC cannabinoid guide covering chemistry, synthesis, effects, potency vs THC, safety concerns, drug testing, legal status, and labeling issues.
Read articleTHC (Tetrahydrocannabinol): Pharmacology, Effects, and Risks
THC is a partial agonist — weaker than your own endocannabinoids. This pharmacological fact explains its biphasic effects, safety ceiling, and medical uses.
Read articleTHC-O Acetate: Effects, Safety, Legal Status, Facts
THC-O acetate is a semi-synthetic cannabinoid with uncertain potency, acetate inhalation risks, sparse human data, and unstable legal status.
Read articleTHCA Explained: Chemistry, Decarb, Testing, and Law
THCA explained: how cannabis makes it, how heat converts it to THC, why HPLC matters, and how high-THCA flower fits the 2018 Farm Bill.
Read articleTHCP Cannabinoid: Effects, Potency, and Legal Status
THCP cannabinoid explained: discovery, seven-carbon structure, potency vs THC, likely effects, research gaps, trace natural levels, and legal status.
Read articleTHCV Cannabinoid Reference: Effects, Studies, Legality
THCV cannabinoid reference covering structure, CB1 dose-switching, diabetes and Parkinson's studies, African strains, legality, dosing, and effects.
Read article